Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Cancers|July 29, 2025
Genes Encoding Multiple Modulators of the Immune Response Are Methylated in the Prostate Tumor Microenvironment of African AmericansVinay Kumar, Tara Sinta Kartika Jennings, Lucas Ueta, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 1, 2005
Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac functionBuddhadeb Dawn, Adam B Stein, Konrad Urbanek, et al.
NPJ Precision Oncology|March 1, 2026
A first-in-human phase 1 study of the SHP2 inhibitor BBP-398 in patients with advanced solid tumorsGerald Falchook, Camila Braganca Xavier, David Van Veenhuyzen, et al.
Journal for Immunotherapy of Cancer|February 25, 2022
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced non-clear cell renal cell carcinoma: results from the phase 3b/4 CheckMate 920 trialScott S Tykodi, Lucio N Gordan, Robert S Alter, et al.
Advances in Radiation Oncology|December 10, 2024
A Predictive Nomogram for Development of Lymph Node Metastasis in Muscle-Invasive Bladder Cancer Following Neoadjuvant TherapyGarrett K Harada, Steven N Seyedin, Olivia Heutlinger, et al.
BMJ Open|September 14, 2022
Safety and efficacy of first-line nivolumab plus ipilimumab alternating with nivolumab monotherapy in patients with advanced renal cell carcinoma: the non-randomised, open-label, phase IIIb/IV CheckMate 920 trialDaniel J George, David R Spigel, Lucio N Gordan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2024
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor TherapyDaniel P Petrylak, Scott T Tagawa, Rohit K Jain, et al.
Cancer Chemotherapy and Pharmacology|March 23, 2021
Niraparib with androgen receptor-axis-targeted therapy in patients with metastatic castration-resistant prostate cancer: safety and pharmacokinetic results from a phase 1b study (BEDIVERE)Fred Saad, Kim N Chi, Neal D Shore, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 16, 2023
Darolutamide Plus Androgen-Deprivation Therapy and Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer by Disease Volume and Risk Subgroups in the Phase III ARASENS TrialMaha Hussain, Bertrand Tombal, Fred Saad, et al.
Future Oncology (London, England)|April 29, 2024
A plain language summary of the TROPHY-U-01 study: sacituzumab govitecan use in people with locally advanced or metastatic urothelial cancerYohann Loriot, Arash Rezazadeh Kalebasty, Aude Fléchon, et al.
Pageof 8